IP Library Granted Patent US 9,982,279
Granted Patent B1
US 9,982,279 · App. 15/632,001 · Granted May 29, 2018

Nucleic acid-guided nucleases

Inventors: Ryan T. Gill (Denver, CO); Andrew Garst (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/902C12N9/22C12N15/11C12N15/70C12N15/81C12N15/85C12N15/905C12N15/907C12N2310/20C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,982,279
App. No.
15/632,001
Granted
May 29, 2018
Kind
B1
Abstract

Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.

Claims (25)

1. A nucleic acid-guided nuclease system comprising:

(a) a nucleic acid-guided nuclease comprising the amino acid sequence of SEQ ID NO: 7, wherein the nucleic-acid guided nuclease is encoded by a wild-type or a codon-optimized nucleic acid;

(b) an engineered guide nucleic acid capable of complexing with the nucleic acid-guided nuclease, wherein the engineered guide nucleic acid comprises any one of SEQ ID NO: 88, SEQ ID NO: 93, and SEQ ID NO: 94, and

(c) an editing sequence having a change in sequence relative to the sequence of a target region in a genome of a cell and a mutation in a protospacer adjacent motif (PAM) site;

wherein the system results in a genome edit in the target region in the genome of the cell facilitated by the nuclease, the engineered guide nucleic acid, and the editing sequence.

2. The system of claim 1 , wherein the engineered guide nucleic acid and the editing sequence are provided as a single nucleic acid.

3. The system of claim 1 , wherein the codon optimized nucleic acid is codon optimized for E. coli.

4. The system of claim 1 , wherein the codon optimized nucleic acid is codon optimized for S. cerevisiae.

5. The system of claim 1 , wherein the codon optimized nucleic acid is codon optimized for mammalian cells.

6. The system of claim 1 , wherein the nucleic acid-guided nuclease has less than 40% protein identity to SEQ ID NO: 12 and SEQ ID NO: 108.

7. The system of claim 1 , wherein the codon optimized nucleic acid is codon optimized for plant cells.

8. The system of claim 1 , wherein the wild-type nucleic acid comprises the sequence of SEQ ID NO: 27.

9. The system of claim 1 , wherein the codon-optimized nucleic acid has at least 95% identity to any one of SEQ ID NO: 47, SEQ ID NO: 133, or SEQ ID NO: 153.

10. A nucleic acid-guided nuclease system comprising:

(a) a nucleic acid comprising SEQ ID NO: 27, SEQ ID NO: 47, SEQ ID NO: 133, or SEQ ID NO: 153, wherein the nucleic acid encodes for a nucleic acid-guided nuclease comprising the amino acid sequence of SEQ ID NO:7;

(b) an engineered guide nucleic acid capable of complexing with the nucleic acid-guided nuclease, and

(c) an editing sequence having a change in sequence relative to the sequence of a target region in a genome of a cell and a mutation in a protospacer adjacent motif (PAM) site;

wherein the system results in a genome edit in the target region in the genome of the cell facilitated by the nuclease, the engineered guide nucleic acid, and the editing sequence.

11. The system of claim 10 , wherein the engineered guide nucleic acid and the editing sequence are provided as a single nucleic acid.

12. The system of claim 10 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for E. coli.

13. The system of claim 10 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for S. cerevisiae.

14. The system of claim 10 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for mammalian cells.

15. The system of claim 10 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for plant cells.

16. The system of claim 10 , wherein the nucleic acid-guided nuclease has less than 40% protein identity to SEQ ID NO: 12 and SEQ ID NO: 108.

17. The system of claim 10 , wherein the engineered guide nucleic acid comprises any one of SEQ ID NO: 88, SEQ ID NO: 93, SEQ ID NO: 94, and SEQ ID NO: 95.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2025
From: INSCRIPTA, INC.,; MANUS INSCRIPTA, INC.
To: MANUS INSCRIPTA, INC.
Reel/Frame 072252/0203 →
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
CHANGE OF NAME Recorded Jan 29, 2018
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 045071/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2017
From: GILL, RYAN T.; GARST, ANDREW; LIPSCOMB, TANYA ELIZABETH WARNECKE
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 043633/0876 →